In This Section:
Dr Ron Fouchier
Ron Fouchier received a PhD in Medicine from the University of Amsterdam in 1995 for studies on HIV and continued to study HIV as a post-doctoral fellow at the Howard Hughes Medical Institute, University of Pennsylvania School of Medicine in Philadelphia, from 1995-1998. He subsequently started a new group to study the molecular biology of respiratory viruses, in particular influenza A virus, at the Viroscience Department of Erasmus MC Rotterdam. As a fellow of the Royal Dutch Academy of Sciences, he studied influenza virus zoonoses and pathogenicity. Recent achievements of his team include the identification and characterization of several “new” viruses; the human metapneumovirus (hMPV), human coronavirus NL63, the SARS coronavirus (SARS-CoV), human coronavirus EMC, and a new influenza A virus subtype (H16). Currently, his research is focused on the evolution and molecular biology of respiratory viruses in humans and animals, with special emphasis on influenza virus zoonoses and pandemics. Fouchier is alumni member of the “Young Academy” of the KNAW, and recipient of the Heine-Medin award of the European Society for Clinical Virology. He authored more than 250 publications that received more than 18000 citations. His current research is funded by an NWO VICI grant, an NIAID/NIH contract, several EU programs, and government. Fouchier is an editor for several infectious disease journals, and member of advisory committees for Dutch government and (international) scientific organisations and conferences. His group is part of an NIH/NIAID Center of Excellence for Influenza Research, and participates in several WHO working groups.